Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
出版年份 2020 全文链接
标题
Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
作者
关键词
-
出版物
JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-06-24
DOI
10.1093/infdis/jiaa377
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
- (2019) Christine A. Bricault et al. Cell Host & Microbe
- Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial
- (2019) Frances H Priddy et al. Lancet HIV
- Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan
- (2019) Jeffrey Umotoy et al. IMMUNITY
- Engineered HIV antibody passes muster
- (2019) Lynn Morris Lancet HIV
- Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
- (2019) Martin R Gaudinski et al. Lancet HIV
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- Monoclonal Antibodies for Emerging Infectious Diseases — Borrowing from History
- (2018) Hilary D. Marston et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials
- (2018) Yunda Huang et al. Human Vaccines & Immunotherapeutics
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
- (2018) Martin R. Gaudinski et al. PLOS MEDICINE
- Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117
- (2018) Yehuda Z. Cohen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
- (2018) Elise Landais et al. Retrovirology
- Preventive and therapeutic features of broadly neutralising monoclonal antibodies against HIV-1
- (2018) Juan P Jaworski et al. Lancet HIV
- Recent progress in broadly neutralizing antibodies to HIV
- (2018) Devin Sok et al. NATURE IMMUNOLOGY
- Antibody-mediated prevention and treatment of HIV-1 infection
- (2018) Henning Gruell et al. Retrovirology
- The expanding array of HIV broadly neutralizing antibodies
- (2018) Laura E. McCoy Retrovirology
- Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline
- (2018) Erin Sparrow et al. VACCINE
- Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins
- (2017) Christian Fercher et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Use of broadly neutralizing antibodies for HIV-1 prevention
- (2017) Amarendra Pegu et al. IMMUNOLOGICAL REVIEWS
- Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
- (2017) Marina Caskey et al. NATURE MEDICINE
- Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial
- (2017) Kenneth H. Mayer et al. PLOS MEDICINE
- Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
- (2017) Yousuf Ahmed et al. AIDS Research and Therapy
- Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
- (2016) Dennis R. Burton et al. Annual Review of Immunology
- Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
- (2016) Ann J Hessell et al. NATURE MEDICINE
- HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
- (2016) T. Schoofs et al. SCIENCE
- Broadly Neutralizing Antibodies for HIV Eradication
- (2016) Kathryn E. Stephenson et al. Current HIV/AIDS Reports
- Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
- (2015) J. E. Ledgerwood et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Anatomical, Physiological, and Experimental Factors Affecting the Bioavailability of sc-Administered Large Biotherapeutics
- (2015) Anas M. Fathallah et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12
- (2015) Evangelia Vamvaka et al. PLANT BIOTECHNOLOGY JOURNAL
- Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants
- (2015) Julian K-C. Ma et al. PLANT BIOTECHNOLOGY JOURNAL
- Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
- (2014) Alejandro B Balazs et al. NATURE MEDICINE
- MABGEL 1: First Phase 1 Trial of the Anti-HIV-1 Monoclonal Antibodies 2F5, 4E10 and 2G12 as a Vaginal Microbicide
- (2014) Georgina C. Morris et al. PLoS One
- HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission
- (2014) Yegor Voronin et al. PLOS MEDICINE
- Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration
- (2012) Yanan Zheng et al. mAbs
- Antibody-based protection against HIV infection by vectored immunoprophylaxis
- (2011) Alejandro B. Balazs et al. NATURE
- Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
- (2011) R. Diskin et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More